The University of California, San Diego will research the mechanisms of heterogeneous neural expression of autism spectrum disorder under a three-year, $868,542 Project Grant from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program administered by the agency under Assistance Listing Number 12.420. This program supports biomedical research that transforms military and public health care through innovative solutions for battlefield...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded Scripps Research Institute, a nonprofit biomedical research organization, a $529,125 project grant to investigate microglia dysfunction in MEF2C deficiency autism spectrum disorder with the goal of discovering targeted therapies. This 3-year award, effective September 30, 2024, will fund research aimed at improving the health and care of military service members, veterans, and their families...
The University of California, San Diego (UCSD) has been awarded a $316,000.00 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). This two-year award, effective from February 1, 2024 to January 31, 2026, will support research to investigate "POSTVIRAL DYNAMICS AND DYSFUNCTION OF THE AUTONOMIC NERVOUS SYSTEM VIA ADHERENCE-INDEPENDENT LONGITUDINAL CARDIOPULMONARY MONITORING." The Military Medical...
The University of California, San Diego will receive $790,000 under a two-year Project Grant award from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program administered by the agency under Catalog of Federal Domestic Assistance number 12.420. The university will conduct research on neuron-targeted caveolin gene therapy as a potential route of administration to treat amyotrophic lateral sclerosis. Specifically, the funding will...
The University of California, San Diego (UCSD) was awarded a $790,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support UCSD research to mitigate traumatic brain injuries and neurological implications via the immunometabolite itaconate from June 1, 2023 through May 31, 2026. The Military Medical Research and Development program aims to transform military and public health care through...
This federal Project Grant award in the amount of $747,507 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports an evaluation of an engineered calpain activity nanosensor in a mouse model of traumatic brain injury (TBI) at the University of California, San Diego (UCSD). The objective of the research is to advance the development of innovative technologies for monitoring and assessing traumatic brain injuries,...
The University of California, San Diego (UCSD) was awarded a $789,987.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on August 1, 2023 with a completion date of July 31, 2026, will support research on CTL-tolerant melanoma persister cells. The research aims to transform health care for Service Members and the American public through innovative and impactful research, and to investigate...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $321,981 to the University of California, Davis to conduct research on "Sensory Processing Contributions to Emotion Dysregulation and Internalizing Problems in Autism". The award period is from April 1, 2025 to March 31, 2027. The research aims to advance understanding of the neural mechanisms underlying sensory processing and...
This Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $681,989.00 to San Diego State University Foundation to conduct research on mapping white matter connectivity of the developing superior temporal sulcus in autism. The 3-year project, running from Jul 1, 2024 to Jun 30, 2027, aims to advance the scientific understanding of neural development and function in autism spectrum disorder. As a non-profit organization...
The Feinstein Institutes for Medical Research received a $921,250 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a study from August 15, 2022 to August 14, 2025 to research microglia as potential therapeutic targets for Autism Spectrum Disorder (ASD) using a mouse model of maternal anti-Caspr2 antibody-induced ASD. The Military Medical Research and Development program supports...